Listing sponsor / Agent
BRYAN, GARNIER AND CO Ltd
Exchange / Market
Direct trading procedure
Initial Public offering
- Number of securities to be listed: 38,318,478 - Reference price: Closing price of the share Oragenics, on the 12/12/2008 on NYSE Alternext US converted in EUR on the basis of EUR/USD exchange rate of the 12/12/2008.
Admission on Alternext 38,318,478 existing common shares representing the outstanding capital of ORAGENICS.
ORAGENICS, which commercial name is ONI BioPharma, is already listed on NYSE Alternext US.
December 15, 2008: listing of the shares issued by ORAGENICS